249 related articles for article (PubMed ID: 17876270)
1. Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation.
Cotler SJ; Kallwitz E; TenCate V; Bhushan A; Berkes J; Benedetti E; Layden-Almer J; Layden TJ; Valyi-Nagy T; Guzman G
Transplantation; 2007 Sep; 84(5):587-91. PubMed ID: 17876270
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
3. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
4. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
[TBL] [Abstract][Full Text] [Related]
5. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
6. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
[TBL] [Abstract][Full Text] [Related]
7. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
[TBL] [Abstract][Full Text] [Related]
9. Are posttransplantation protocol liver biopsies useful in the long term?
Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
[TBL] [Abstract][Full Text] [Related]
10. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
11. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
13. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
15. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
[TBL] [Abstract][Full Text] [Related]
17. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
[TBL] [Abstract][Full Text] [Related]
18. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
[TBL] [Abstract][Full Text] [Related]
19. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
[TBL] [Abstract][Full Text] [Related]
20. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
Sánchez-Pérez B; Aranda Narváez JM; Santoyo Santoyo J; Fernández-Aguilar JL; Suárez Muñoz MA; González-Sánchez AJ; Pérez Daga JA; Ramírez Plaza CP; Carrasco Campos J; Jiménez Mazure C; Becerra Ortíz R
Transplant Proc; 2008 Nov; 40(9):2994-6. PubMed ID: 19010171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
